ORAGENICS INC

OGEN

ORAGENICS INC

OGEN

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2025-12-12Shares Purchased (TTM):0Shares Sold (TTM):420

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:154,193Shares Outstanding:4,300,980Institutional Ownership Pct.:3.59%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	4	6	4	11	2	3	1	3	1	2	3	6
Assets Current
Assets Current	5	7	10	13	2	4	1	4	2	2	4	8
Other Receivables Net Current	-	-	-	-	-	-	-	-	-	-	-	0
Short Term Investments	-	-	4	-	-	-	-	-	-	-	-	-
Interest Receivable	-	-	0	-	-	-	-	-	-	-	-	-
Prepaid Expense And Other Assets Current	2	1	2	1	0	0	1	1	0	0	0	2
Property Plant And Equipment Net	-	-	-	-	-	-	-	-	-	-	0	0
Prepaid Expense Noncurrent	-	-	-	-	-	-	-	-	-	-	1	-
Operating Lease Right Of Use Asset	-	-	-	-	-	-	-	-	-	-	0	0
Assets	5	7	10	13	2	4	1	5	3	4	5	8
Liabilities And Stockhold…
Deposits Assets Noncurrent	-	-	-	-	-	-	-	-	-	-	-	0
Accounts Payable And Accrued Liabilities Current	2	1	2	2	1	1	1	2	1	1	1	1
Liabilities Current
Liabilities Current	-	-	-	-	-	-	-	-	-	-	2	1
Notes Payable Current	-	0	0	0	3	3	0	1	-	0	0	0
Operating Lease Liability Current	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities	2	1	2	3	4	4	2	2	1	1	2	-
Preferred Stock Value	-	-	-	-	-	-	-	2	2	2	2	2
Liabilities Noncurrent
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Stockholders Equity	4	6	8	10	-2	0	-0	3	1	3	3	6
Additional Paid In Capital	235	235	235	234	219	219	217	215	211	210	208	198
Retained Earnings Accumulated Deficit	-231	-229	-227	-224	-221	-219	-217	-213	-211	-209	-206	-193
Liabilities And Stockholders Equity	5	7	10	13	2	4	1	5	3	4	5	8
Preferred Stock No Par Value	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	50	50	50	50	50	50	50	50	50	50	50	50
Preferred Stock Shares Outstanding	-	-	-	-	-	-	7	-	-	-	17	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	350	350	350	350	350	350	350	350	350	350	350	4
Common Stock Shares Issued	5	4	4	4	1	1	0	0	0	0	0	0
Shares Outstanding	5	4	4	4	1	1	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	1.67%	-1.67%	-15.00%	-	-	-	-	-	-	-	-	-
2025	-29.41%	-20.59%	-72.75%	-11.21%	9.48%	13.79%	-22.32%	-23.21%	-23.21%	-25.00%	-25.00%	-26.25%
2024	1.83%	-37.80%	-42.07%	-9.29%	-71.43%	-77.86%	8.82%	0.00%	-8.82%	-32.14%	-32.14%	-57.14%
2023	-	-	-	-	-	-	-7.73%	50.13%	28.00%	-	-	-
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	-	-	-	-	-	-	-	-	-	-	2.15	5.57
Quick Ratio	-	-	-	-	-	-	-	-	-	-	1.94	4.14
Working Capital	-	-	-	-	-	-	-	-	-	-	2.07M	6.41M
Leverage & Debt
Debt to Equity	-	-	-	-	-	-	-	-	-	-	0.57	0.22
Interest Coverage TTM	-561.90	-16.24	-11.91	-12.95	-12.03	-45.63	-353.99	-643.28	-557.03	-596.00	-683.37	-430.61
Debt Ratio	-	-	-	-	-	-	-	-	-	-	0.36	0.18
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-2.28	-2.28	-4.56	-6.99	-14.08	-17.02	-47.88	-91.76	-129.27	-174.04	-275.72	-129.32
Free Cash Flow Per Share TTM	-2.30	-2.17	-4.29	-5.40	-10.13	-12.59	-38.95	-35.30	-47.79	-70.83	-97.32	-109.93
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-	-	-	-	-	-	-	-	-263,285.20%	-99,181.69%	-55,519.89%	-27,645.11%
Net Profit Margin TTM	-	-	-	-	-	-	-	-	-261,401.51%	-98,219.66%	-54,858.14%	-26,946.19%
Growth Metrics
Net Revenue Growth (1Y)	-	-	-	-	-100.00%	-100.00%	-100.00%	-100.00%	-93.58%	-84.54%	-71.37%	-71.37%
Net Income Growth (1Y)	-2.11%	-4.91%	-6.86%	-45.38%	-47.22%	-49.00%	-48.84%	96.79%	62.59%	61.55%	44.56%	-29.26%
EPS Growth (1Y)	-83.82%	-86.58%	-90.47%	-92.39%	-89.11%	-90.22%	-82.64%	-29.05%	-27.38%	1.88%	29.11%	-41.58%
Valuation Metrics
P/E TTM	-0.25	-0.25	-0.17	-0.19	-0.27	-0.37	-0.23	-0.12	-0.24	-0.25	-0.61	-0.69
P/B TTM	0.70	0.39	0.20	0.21	-1.31	27.78	-11.56	0.81	3.55	1.92	3.99	1.08
P/S TTM	-	-	-	-	-	-	-	-	630.89	243.80	336.05	185.66
Market Cap	2.57M	2.41M	1.68M	2.04M	2.80M	3.83M	2.45M	2.48M	4.71M	5.03M	12.65M	6.99M
Enterprise Value	-1.30M	-3.64M	-2.49M	-8.96M	3.82M	2.96M	1.91M	-143.99K	3.36M	3.08M	9.48M	1.72M
Calculated Values
Free Cash Flow TTM	-10.21M	-9.33M	-9.25M	-8.43M	-7.42M	-7.65M	-8.60M	-7.68M	-7.21M	-8.25M	-7.29M	-8.62M
Net Debt	-3.86M	-6.05M	-4.17M	-11.01M	1.03M	-866.69K	-536.31K	-2.62M	-1.35M	-1.95M	-3.17M	-5.27M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-12Sale

Owner: Telling, Fred

Title: -

Shares: 210

Price/Share: $0.94

Value: $197.40

Shares Owned: 34,538

Relationship: Director

Ownership: Direct

2025-12-12Sale

Owner: Telling, Fred

Title: -

Shares: 210

Price/Share: $0.94

Value: $197.40

Shares Owned: 948

Relationship: Director

Ownership: Direct

2025-06-18Sale

Owner: Odyssey, Health, Inc.

Title: -

Shares: 5,044

Price/Share: $4.26

Value: $21,487.44

Shares Owned: -

Relationship: TenPercentOwner

Ownership: Direct

2025-06-16Sale

Owner: Odyssey, Health, Inc.

Title: -

Shares: 5,000

Price/Share: $4.45

Value: $22,250.00

Shares Owned: 7,044

Relationship: TenPercentOwner

Ownership: Direct

2024-12-06Sale

Owner: Telling, Fred

Title: -

Shares: 3,597

Price/Share: $0.36

Value: $1,294.92

Shares Owned: 34,748

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-12	Telling, Fred	Director	-	Direct	Sale	210	0.94	$197.40	34,538	4
2025-12-12	Telling, Fred	Director	-	Direct	Sale	210	0.94	$197.40	948	4/A
2025-06-18	Odyssey, Health, Inc.	TenPercentOwner	-	Direct	Sale	5,044	4.26	$21,487.44	0	4
2025-06-16	Odyssey, Health, Inc.	TenPercentOwner	-	Direct	Sale	5,000	4.45	$22,250.00	7,044	4
2024-12-06	Telling, Fred	Director	-	Direct	Sale	3,597	0.36	$1,294.92	34,748	4
2024-12-06	Dunton, Alan W	Director	-	Direct	Sale	66	0.36	$23.76	25,623	4
2023-11-30	Telling, Fred	Director	-	Direct	Sale	3,500	3.57	$12,495.00	38,345	4
2022-12-30	Koski, Robert C	Director	-	Indirect	Sale	42,357	0.11	$4,659.27	1,102,295	4
2022-12-15	Koski, Robert C	Director	-	Indirect	Sale	140,497	0.18	$25,289.46	1,144,652	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

3.59%

Inst. Shares: 154,193

Shares Outstanding: 4,300,980

2025-12-31

10.02%

Inst. Shares: 216,109

Shares Outstanding: 2,157,076

2025-09-30

7.83%

Inst. Shares: 122,200

Shares Outstanding: 1,560,909

2025-06-30

14.04%

Inst. Shares: 102,768

Shares Outstanding: 731,817

2025-03-31

45.03%

Inst. Shares: 273,410

Shares Outstanding: 607,208

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	154,193	4,300,980	3.59%
2025-12-31	216,109	2,157,076	10.02%
2025-09-30	122,200	1,560,909	7.83%
2025-06-30	102,768	731,817	14.04%
2025-03-31	273,410	607,208	45.03%
2024-12-31	216,553	220,731	98.11%
2024-09-30	115,919	217,602	53.27%
2024-06-30	117,917	150,968	78.11%
2024-03-31	107,837	116,419	92.63%
2023-12-31	46,658	74,915	62.28%
2023-09-30	47,858	78,457	61.00%
2023-06-30	39,763	67,425	58.97%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

ORAGENICS INC (OGEN) — SEC Financial Statements & Analysis

ORAGENICS INC (OGEN) is a pharmaceutical preparations company, incorporated in FL. ORAGENICS INC trades on NYSE as: OGEN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), ORAGENICS INC reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.57x, a Price-to-Sales (P/S) ratio of 630.89x (TTM), a Price-to-Book (P/B) ratio of 0.70x (TTM), at a market cap of $2.57M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 0.57x
P/S TTM: 630.89x
P/B TTM: 0.70x
Market Cap: $2.57M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ORAGENICS INC in?

ORAGENICS INC (OGEN) operates in the Pharmaceutical Preparations industry.

What is OGEN's market cap?

ORAGENICS INC (OGEN) has a market capitalization of $2.57M as of 2026-06-30.

What exchange does OGEN trade on?

ORAGENICS INC (OGEN) trades on the NYSE.

Where is ORAGENICS INC incorporated?

ORAGENICS INC is incorporated in FL.

ORAGENICS INC

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

ORAGENICS INC (OGEN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

ORAGENICS INC (OGEN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.